The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 288 participants.
Also called NCT05231694
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 288 participants
- Registry
-
NCT05231694
-
- Other papers using this trial's data
- Specific mode acupoint electrical stimulation combined with NGF for neurological recovery in ischemic stroke convalescence: A randomized controlled study
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05231694. Randomized; triple masking; primary purpose treatment. Start 2022-04-01 (actual); primary completion 2025-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Nerver growth factor (NGF) injection
- Intervention (Drug)
- Placebo injection
- Intervention (Device)
- EA intervention
- Intervention (Device)
- sham EA intervention
- Lead sponsor
- The Third Affiliated hospital of Zhejiang Chinese Medical University
- Collaborator
- Ningbo No.2 Hospital
- Collaborator
- second people hospital of lishui
Record details
- Record id
cardio:ct-nct05231694- Content hash
86ccfc38a6cdee47a4f77644d51d2f7285eb35c7bb204621a6842d303c9ef32d